/002675.SZ
002675.SZ Stock - Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
Basic Materials|ChemicalsSHZ
$13.70+2.01%
+$0.27 (+2.01%) • Dec 25
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $15.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 002675.SZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$13.56 – $13.84
TARGET (TP)$15.75
STOP LOSS$12.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.04
52W High$18.68
52W Low$11.95
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.87B | $3.28B | $3.58B | $3.91B | $3.42B |
| Gross Profit | $1.35B | $1.35B | $1.53B | $1.59B | $1.66B |
| Gross Margin | 47.0% | 41.3% | 42.8% | 40.6% | 48.7% |
| Operating Income | $220.81M | $341.66M | $448.25M | $356.93M | $609.14M |
| Net Income | $183.83M | $209.74M | $307.29M | $151.56M | $417.77M |
| Net Margin | 6.4% | 6.4% | 8.6% | 3.9% | 12.2% |
| EPS | $0.22 | $0.25 | $0.38 | $0.19 | $0.52 |
Company Overview
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
002675.SZBeat Rate
33%
Last 3 quarters
Avg Surprise
-50.3%
EPS vs Estimate
Beats / Misses
1/2
Last 12 quarters
Latest EPS
$0.07
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
-74.3%
$0.02vs$0.08
Q2 25
-81.3%
$0.03vs$0.16
Q4 25
+4.7%
$0.07vs$0.07
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 29, 2025 | $0.07 | $0.07 | +4.7% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $0.16 | $0.03 | -81.3% | ✗ MISS |
Q1 2025 | Feb 26, 2025 | $0.08 | $0.02 | -74.3% | ✗ MISS |
Q4 2024 | Oct 28, 2024 | — | $0.07 | — | — |
Q3 2024 | Aug 30, 2024 | — | $0.06 | — | — |
Q2 2024 | Apr 27, 2024 | — | $0.08 | — | — |
Q1 2024 | Jan 17, 2024 | — | $-0.09 | — | — |
Q4 2023 | Oct 26, 2023 | — | $0.12 | — | — |
Q3 2023 | Aug 23, 2023 | — | $0.16 | — | — |
Q2 2023 | Apr 29, 2023 | — | $-0.03 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.06 | — | — |
Q4 2022 | Oct 27, 2022 | — | $0.20 | — | — |
Q3 2022 | Aug 25, 2022 | — | $0.14 | — | — |
Q2 2022 | Apr 28, 2022 | — | $0.07 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.07 | — | — |
Q4 2021 | Oct 28, 2021 | — | $0.13 | — | — |
Q3 2021 | Jul 27, 2021 | — | $0.11 | — | — |
Q2 2021 | Apr 30, 2021 | — | $0.10 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.08 | — | — |
Q4 2020 | Oct 26, 2020 | — | $0.15 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 002675.SZ
What is 002675.SZ's current stock price?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (002675.SZ) is currently trading at $13.70 per share. The stock has moved +2.01% today.
What is the analyst price target for 002675.SZ?
No analyst price targets are currently available for this stock.
What sector is Yantai Dongcheng Pharmaceutical Group Co.,Ltd. in?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. operates in the Basic Materials sector, specifically within the Chemicals industry. The company is traded on the SHZ exchange.
What is 002675.SZ's market cap?
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. has a market capitalization of $11.30 billion, making it a large-cap company.
Does 002675.SZ pay dividends?
No, Yantai Dongcheng Pharmaceutical Group Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials Sector002192.SZ
YOUNGY Co.,Ltd.
$52.68
Mkt Cap: $13.7B
002643.SZ
Valiant Co.,Ltd
$15.95
Mkt Cap: $14.7B
300769.SZ
Shenzhen Dynanonic Co., Ltd
$44.45
Mkt Cap: $12.4B
300777.SZ
Sinofibers Technology Co.,Ltd.
$35.80
Mkt Cap: $15.7B
600063.SS
Anhui Wanwei Updated High-Tech Material Industry Co.,Ltd
$6.10
Mkt Cap: $13.0B
600328.SS
CNSIG Inner Mongolia Chemical Industry Co., Ltd.
$8.04
Mkt Cap: $11.7B
600458.SS
Zhuzhou Times New Material Technology Co., Ltd.
$13.54
Mkt Cap: $12.6B
605020.SS
Zhejiang Yonghe Refrigerant Co., Ltd.
$27.20
Mkt Cap: $13.9B
605376.SS
Jiangsu Boqian New Materials Stock Co., Ltd.
$65.00
Mkt Cap: $17.0B
688690.SS
Suzhou Nanomicro Technology Co., Ltd.
$26.04
Mkt Cap: $10.4B
Explore stocks similar to 002675.SZ for comparison